Happy Holidays from Zelmic – Reflecting on a Year of Growth and Collaboration
As 2025 comes to a close, we at Zelmic AB would like to extend our sincere thanks to our clients, collaborators, and partners for a truly remarkable year. This year has been a period of innovation and transformation in topical and transdermal drug development. Together, we have continued to advance projects that push the boundaries…
Continue Reading
